Recurrent Solid Neoplasm Recruiting Phase 1 / 2 Trials for DB11740 (MK-1775)

IndicationStatusPhase
DBCOND0080814 (Recurrent Solid Neoplasm)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02095132WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid TumorsTreatment